KaydedilenlerDerginizi ekleyin

Dergiler / Journal of the Turkish Chemical Society Section A: Chemistry / 2020 / Cilt: 7 - Sayı: 2

Antioxidant Enzyme Activities in Ascorbic Acid and Selenium Applied Hepatocellular Carcinoma Cells

Burcu Menekşe BALKAN
Öğünç MERAL
Gorkem KİSMALİ
Tevhide SEL
Sayfa
581–588
Yayın Tarihi
2020-06-23
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The results of the present study indicated that the antioxidant enzyme activities changed depending on Org Se, SeO2 application and CAT activities changed depending on Ascorbic Acid doses.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Ascorbic Acid and selenium has a potential use in the prevention of cancer.
📊
Temel Bulgular & Veri:The aim of the study was to investigate the effect of Ascorbic Acid and selenium on antioxidant enzyme activities in HepG2 cell line.
💡
Sonuç & Katkı:The results of the present study indicated that the antioxidant enzyme activities changed depending on Org Se, SeO2 application and CAT activities changed depending on Ascorbic Acid doses.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Antioxidant enzymes · Ascorbic acid · HepG2 Cells

Abstract

Ascorbic Acid and selenium has a potential use in the prevention of cancer. The role of antioxidant enzymes against cancer is to prevent oxidative damage. The aim of the study was to investigate the effect of Ascorbic Acid and selenium on antioxidant enzyme activities in HepG2 cell line. In this study, the effects of Org Se (234 µM), SeO2 (100 µM), Ascorbic Acid (31,3 mM) and Ascorbic Acid (0,313 mM) on antioxidant enzyme activities in HepG2 cell line were studied. GPx, CAT and SOD activities were measured spectrophotometrically. There was a significant increase in the activity of GPx in HepG2 cells treated with Org Se (234 µM), SeO2 (100 µM), Ascorbic Acid (31,3 mM) and Ascorbic Acid (0,313 mM), however the activity of CAT was found significantly decreased in Org Se (234 µM), SeO2 (100 µM), Ascorbic Acid (31,3 mM) treated HepG2 cells. The SOD levels of HepG2 cells treated with Ascorbic Acid (31,3 mM) and AA (0,313 mM) were found higher than the control cells. The results of the present study indicated that the antioxidant enzyme activities changed depending on Org Se, SeO2 application and CAT activities changed depending on Ascorbic Acid doses.

🔖

Bu Makaleye Atıf Yap

BALKAN, B. M., MERAL, Ö., KİSMALİ, G., SEL, T. (2020). Antioxidant Enzyme Activities in Ascorbic Acid and Selenium Applied Hepatocellular Carcinoma Cells. Journal of the Turkish Chemical Society Section A: Chemistry, Cilt: 7 - Sayı: 2, 581–588. https://ajindex.com/articles/781227

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med. 2007;43(1):4–15. Doi: 10.1016/j.freeradbiomed.2007.03.024
  2. Zou Z, Chang H, Li H, Wang S. Induction of reactive oxygen species: an emerging approach for cancer therapy. Apoptosis. 2017;22(11):1321–35. doi: 10.1007/s10495-017-1424-9
  3. Hatem E, Azzi S, El Banna N, He T, Heneman-Masurel A, Vernis L, et al. Auranofin/Vitamin C: A novel drug combination targeting triple-negative breast cancer. J Natl Cancer Inst. 2019;111(6):597-608. doi: 10.1093/ije/djy149
  4. Shaaban S, Ashmawy AM, Negm A, Wessjohann LA. Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma. Eur J Med Chem. 2019;179:515-526. doi:10.1016/j.ejmech.2019.06.075
  5. Du J, Martin SM, Levine M, Wagner BA, Buettner GR, Wang SH, et al. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res. 2010;16(2):509–20. doi: 10.1158/1078-0432.CCR-09-1713
  6. Paolini M, Pozzetti L, Pedulli GF, Marchesi E, Cantelli-Forti G. The nature of prooxidant activity of vitamin C. Life Sci. 1999;64(23):273-278. Doi: 10.1016/s0024-3205(99)00167-8
  7. Fernandes AP, Gandin V. Selenium compounds as therapeutic agents in cancer. Biochim Biophys Acta - Gen Subj. 2015;1850(8):1642–60. doi: 10.1016/j.bbagen.2014.10.008
  8. Misra S, Boylan M, Selvam A, Spallholz JE, Björnstedt M. Redox-active selenium compounds—from toxicity and cell death to cancer treatment. Nutrients. 2015;7(5):3536–56. doi: 10.3390/nu7053536
  9. Head KA. Ascorbic acid in the prevention and treatment of cancer. Altern Med Rev. 1998;3(3):174–86. PMID: 9630735
  10. Combs GF. Status of selenium in prostate cancer prevention. Br J Cancer. 2004;91(2):195–9. Doi: 10.1038/sj.bjc.6601974
  11. Knekt P, Marniemi J, Teppo L, Heliövaara M, Aromaa A. Is low selenium status a risk factor for lung cancer? Am J Epidemiol. 1998;148(10):975–82. Doi: 10.1093/oxfordjournals.aje.a009574
  12. Mandrioli J, Michalke B, Solovyev N, Grill P, Violi F, Lunetta C, et al. Elevated levels of selenium species in cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated gene mutations. Neurodegener Dis. 2017;17(4–5):171–80. doi: 10.1159/000460253
  13. Vinceti M, Chiari A, Eichmüller M, Rothman KJ, Filippini T, Malagoli C, et al. A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment. Alzheim